Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Dr.Ci:Labo Co Ltd (4924)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Dr.Ci:Labo Co Ltd historical data, for real-time data please try another search
5,890.0 0.0    0.00%
19/04 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3638700009 
  • Volume: 0
  • Bid/Ask: 5,890.0 / 5,900.0
  • Day's Range: 5,890.0 - 5,900.0
Dr.Ci:Labo Co Ltd 5,890.0 0.0 0.00%

4924 Balance Sheet

 
Featured here, the Balance Sheet for Dr.Ci:Labo Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2019
31/01
2018
31/10
2018
31/07
2018
30/04
Total Current Assets 30430.42 34932.03 37508.66 35779.14
Cash and Short Term Investments 18995.64 22644.99 24774.55 22945.99
Cash - - - -
Cash & Equivalents 18945.54 22593.24 24723.94 22896.34
Short Term Investments 50.11 51.74 50.61 49.66
Total Receivables, Net 3606.6 4405.62 6141.69 4806.49
Accounts Receivables - Trade, Net 3606.6 4405.62 6141.69 4806.49
Total Inventory 5861.43 5701.43 5143.43 5025.83
Prepaid Expenses - - - -
Other Current Assets, Total 1966.74 2179.99 1448.99 3000.83
Total Assets 45881.68 50726.13 53001.73 50791.03
Property/Plant/Equipment, Total - Net 3481.87 3466.84 3470.47 3352.17
Property/Plant/Equipment, Total - Gross 6244.09 6227.49 6147.86 5183.73
Accumulated Depreciation, Total -2762.22 -2760.65 -2677.39 -1831.56
Goodwill, Net 6038.42 6240.86 6443.29 8314.61
Intangibles, Net 4056.55 4171.02 4255.46 2065.36
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1874.43 1915.38 1323.84 1279.74
Other Assets, Total - - - -
Total Current Liabilities 10821.33 13995.46 13592.67 14109.59
Accounts Payable 669.7 1153.51 1058.1 1407.58
Payable/Accrued - - - -
Accrued Expenses 120.47 203.04 126.05 200.74
Notes Payable/Short Term Debt - 800 - 800
Current Port. of LT Debt/Capital Leases 800 - 800 -
Other Current liabilities, Total 9231.17 11838.91 11608.52 11701.27
Total Liabilities 14436.59 18893.69 18641.88 18591.65
Total Long Term Debt 2276 2474 2672 2870
Long Term Debt 2276 2474 2672 2870
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - 1072.23 1048.63 1019.76
Other Liabilities, Total 1339.27 1352 1328.57 592.29
Total Equity 31445.09 31832.44 34359.85 32199.38
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 2959.36 2959.36 2959.36 2959.36
Additional Paid-In Capital 2708.99 3436.76 3436.76 3436.76
Retained Earnings (Accumulated Deficit) 25743.36 25364.46 27916.95 25785.6
Treasury Stock - Common -5.15 -0.78 -0.62 -0.62
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) 17.52 18.9 23.37 23.28
Other Equity, Total 21.01 53.74 24.04 -4.99
Total Liabilities & Shareholders' Equity 45881.68 50726.13 53001.73 50791.03
Total Common Shares Outstanding 48.63 48.64 48.64 48.64
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4924 Comments

Write your thoughts about Dr.Ci:Labo Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email